AVBPArriVent BioPharma, Inc.

$31.16

Who owns AVBP

137 institutions reported holding AVBP for 2026Q1, together 93% of the company, more than the 120 a quarter earlier.

137

Institutions reporting a position · as of 2026Q1 · up from 120 the quarter before

Shares held by institutions
42.1M

Shares held by institutions · 93% of the company · long US equity positions only, as reported on Form 13F

Reported value
$969M

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
41%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
9
New positions
28
Positions exited
17
Added to
56
Reduced
28
Top 10 holdersof the company
64%
Institutional ownership by quarter, 2024Q1 to 2026Q1
QuarterFilersSharesReported value
2026Q113742.1M$969M
2025Q412040.1M$810M
2025Q310438.6M$712M
2025Q29833.6M$732M
2025Q18229.1M$539M
2024Q47928.5M$757M
2024Q36825.9M$612M
2024Q25421.7M$404M
2024Q15321.9M$389M
Largest reported holders, 2026Q1
HolderShares% of companyValue
SUVRETTA CAPITAL MANAGEMENT, LLC4.4M9.8%$102M
INFINITUM ASSET MANAGEMENT, LLC4.1M9.2%$96M
HILLHOUSE CAPITAL ADVISORS, LTD.3.9M8.7%$91M
ORBIMED ADVISORS LLC3.0M6.7%$70M
FMR LLC3.0M6.7%$70M
BlackRock Inc.2.5M5.6%$58M
VANGUARD GROUP INC2.0M4.5%$47M
Octagon Capital Advisors LP2.0M4.4%$45M
NOVO HOLDINGS A/S1.9M4.3%$45M
Sofinnova Investments, Inc.1.7M3.8%$39M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…